Aphelion Capital

California
Founded:2006
Firm Location:California • Massachusetts • San Francisco, California • Denver, Colorado
Aphelion Capital Team
Photo of John Kim, Managing Director at Aphelion Capital
John Kim
Aphelion Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
Investors in Medical Devices (Seed), Investors in Analytics (Series A), Investors in Analytics (Seed), Investors in IoT (Seed), Investors in Medical Devices (Series A), Investors in IoT (Series A), Investors in Health IT (Series A), Investors in Analytics (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in IoT (Seed), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Analytics (Series A), Investors in Health IT (Series A), Investors in IoT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed)
Photo of Jacob Martellaro (Jake), Venture Partner at Aphelion Capital
Jacob Martellaro (Jake)
Aphelion Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Massachusetts
Investors in FinTech (Series B), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Bob Mellen, Venture Partner at Aphelion Capital
Bob Mellen
Aphelion Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA), Investors in Boston (MA)
Photo of Ned Scheetz, Managing Partner at Aphelion Capital
Ned Scheetz
Aphelion Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Denver (CO)
Investors in Analytics (Series B), Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Analytics (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Analytics (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Seed), Investors in Analytics (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Analytics (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Analytics (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Colorado / Utah (Other Lists), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed)
Photo of Lisa Suennen, Venture Partner at Aphelion Capital
Lisa Suennen
Aphelion Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in California
Photo of Robert Thomas, Venture Partner at Aphelion Capital
Robert Thomas
Aphelion Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)